Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001080014

INVA

Innoviva, Inc.
$20.50 ▼ -0.24%
Prev close $20.55
Market cap$1.5B
ConsensusStrong Buy
12-mo target$35.00 (+70.7%)
▲ Bullish
Analyst conviction 8/10
25 New Institutional Positions16 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on INVA right now — valuation, ownership and activity at a glance.
Market Cap
$1.5B
Cap Size
Small Cap
Analyst Consensus
Strong Buy (82%)
Inst. Holders
50 funds
Inst. Value
$1.4B
Inst. Activity
25 buys / 16 sells
Social Sentiment
67° Warm
SEC Reports
3
Price chart 30d -4.0%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 17, 2026 short_volume
Short Volume: INVA — 74.9% short (0.4M / 0.5M)
Short: 387,669 | Exempt: 319 | TRF Vol: 517,814 | Short Ratio: 74.9% | Off-exchange volume (dark poo
Aug 20, 2026 Insider
Raifeld Pavel surrendered for taxes 1,130 shares
Chief Executive Officer @ $21.00 ($23.7K)
Aug 20, 2026 Insider
Basso Stephen surrendered for taxes 558 shares
Chief Financial Officer @ $21.00 ($11.7K)
Aug 20, 2026 Insider
Zhen Marianne surrendered for taxes 1,127 shares
Chief Accounting Officer @ $21.00 ($23.7K)
Jun 30, 2026 Inst.
Integrated Wealth Concepts LLC — DOUBLED
350,575 shares ($8.0M)
Jun 30, 2026 Inst.
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP — NEAR_EXIT
340,168 shares ($7.7M)
May 18, 2026 SEC
Innoviva reported the resignations of board members Derek Small and Mark DiPaolo to focus on their roles at Syndeio BioS
8-K — Impact 3/10
May 6, 2026 SEC
Innoviva reported Q1 2026 total revenue of $98.0M (+11% YoY, slightly below $101.6M consensus) and diluted EPS of $2.22,
8-K — Impact 5/10
Analyst ratings buy % +2.5%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Strong Buy 82% rate it Buy or better · 11 analysts
Strong Buy 4 36% Buy 5 45% Hold 1 9% Sell 1 9% Strong Sell 0 0%
Recent analyst actions
DateFirmActionRatingFirm rating
Aug 7, 2026Cantor FitzgeraldMAINTAINOverweight 49%
Jun 22, 2026BTIGMAINTAINBuy 53%
Jun 1, 2026HC Wainwright & Co.REITERATEBuy 43%
May 26, 2026BTIGREITERATEBuy 53%
May 7, 2026BTIGMAINTAINBuy 53%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Sep 1, 20264511082%
Aug 1, 20264511082%
Jul 1, 20264511082%
Jun 1, 20264511082%
May 1, 20264511082%
Apr 1, 20264511082%
Mar 1, 20264511082%
Feb 1, 20263511080%
Price targets
Where 5 covering analysts think INVA trades over the next 12 months.
$35.00 +70.7% upside Strong Buy
Current$20.50 Low$18.00 Median$35.00 High$46.00 5 analysts
$18.00$46.00
Analyst rating Buy· 1.8/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
67°
Warm
BearishNeutralBullish
2 mentions 2 bullish 0 bearish 0 neutral
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
3 SEC filing reports analyzed · 0 bullish, 0 bearish, 1 mixed, 2 neutral · avg impact 3.7/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 17, 2026
short_volume
Short Volume: INVA — 74.9% short (0.4M / 0.5M)
Short: 387,669 | Exempt: 319 | TRF Vol: 517,814 | Short Ratio: 74.9% | Off-exchange volume (dark pool + OTC)
Jul 29, 2026
earnings_calendar
INVA Q2 2026 Earnings Scheduled — 2026-07-29
Jul 8, 2026
ftd
FTD: INVA — 27,821 shares ($0.6M) failed to deliver
Settlement: 20260708, Price: $22.25, FTD Value: $619,017.25, INNOVIVA INC COM STK (DE)
May 22, 2026
short_volume
Short Volume: INVA — 82.1% short (0.6M / 0.7M)
Short: 589,297 | Exempt: 223,800 | TRF Vol: 717,911 | Short Ratio: 82.1% | Off-exchange volume (dark pool + OTC)
May 18, 2026
ftd
FTD: INVA — 85,630 shares ($1.9M) failed to deliver
Settlement: 20260518, Price: $21.97, FTD Value: $1,881,291.1, INNOVIVA INC COM STK (DE)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$0.34$-0.36–$0.57-68.5%+38.2%1↑ 0↓$0.1B5
Next Q$0.52$0.46–$0.61-73.1%-8.7%1↑ 1↓$0.1B5
Current FY$2.23$1.49–$2.56-32.3%+3.8%0↑ 1↓$0.5B5
Next FY$2.26$1.92–$2.831.3%-2.9%1↑ 1↓$0.5B5
Current-quarter EPS estimate — revision history
WhenEPS estimateChange vs now
Current$0.340—
7d ago$0.246+0.094
30d ago$0.246+0.094
60d ago$0.380-0.040
90d ago$0.380-0.040
Institutional ownership
Which big funds own INVA (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $1.4B total value (62,275,379 shares) as of 2026-Q2. Top holders: BlackRock,, DIMENSIONAL, VANGUARD. Net buying activity: 25 institutions added/increased vs 16 reduced.
Top holders — 2026-Q2
FundSharesValue% TrackedLast move
BlackRock, Inc.11,555,209$262.4M18.6%—
DIMENSIONAL FUND ADVISORS LP4,494,053$102.1M7.2%—
VANGUARD PORTFOLIO MANAGEMENT LLC4,220,273$95.8M6.8%—
RENAISSANCE TECHNOLOGIES LLC4,036,532$91.7M6.5%—
STATE STREET CORP3,268,004$74.2M5.2%—
VANGUARD CAPITAL MANAGEMENT LLC3,158,053$71.7M5.1%—
MILLENNIUM MANAGEMENT LLC2,541,109$57.7M4.1%ADD +41.6%
GEODE CAPITAL MANAGEMENT, LLC2,074,709$47.1M3.3%—
Boston Partners1,927,959$43.8M3.1%—
BANK OF AMERICA CORP /DE/1,667,697$37.9M2.7%—
Recent position changes
FundActionPrevCurrentChangeValue
Integrated Wealth Concepts LLCDOUBLED165,214350,575+112.2%$8.0M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPNEAR_EXIT1,887,570340,168-82.0%$7.7M
Empowered Funds, LLCADD168,055326,197+94.1%$7.4M
ENVESTNET ASSET MANAGEMENT INCDOUBLED32,470217,646+570.3%$4.9M
PRUDENTIAL FINANCIAL INCADD136,417195,907+43.6%$4.4M
Creative PlanningDOUBLED79,770194,702+144.1%$4.4M
BARCLAYS PLCTRIM430,879169,530-60.7%$3.9M
D. E. Shaw & Co., Inc.TRIM248,819166,255-33.2%$3.8M
JPMORGAN CHASE & COTRIM350,571143,390-59.1%$3.4M
Freestone Grove Partners LPADD81,846118,877+45.2%$2.7M
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
8 insiders, 28 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
DateInsiderTitleTypeSharesPriceValue
Aug 20, 2026Raifeld PavelChief Executive OfficerTAX W/H1,130$21.00$23.7K
Aug 20, 2026Basso StephenChief Financial OfficerTAX W/H558$21.00$11.7K
Aug 20, 2026Zhen MarianneChief Accounting OfficerTAX W/H1,127$21.00$23.7K
May 20, 2026Raifeld PavelChief Executive OfficerTAX W/H1,130$22.24$25.1K
May 20, 2026Zhen MarianneChief Accounting OfficerTAX W/H1,127$22.24$25.1K
May 20, 2026Basso StephenChief Financial OfficerTAX W/H559$22.24$12.4K
May 18, 2026Linden JosephineDirectorAWARD5,733——
May 18, 2026Linden JosephineDirectorAWARD9,166——
May 18, 2026Linden JosephineDirectorAWARD9,461——
May 15, 2026Raifeld PavelChief Executive OfficerAWARD1,123——
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for INVA.
Shares short
7,144,265
Settlement Sep 15, 2026
Change vs prior
+2.9%
Semi-monthly cycle
Days to cover
9.3
At avg daily volume
Of shares outstanding
≈9.9%
Estimate — not % of float
All INVA filing & press-release reports (3)